CJC-1295 Without DAC and Ipamorelin Dosage: What Research Shows

In research settings, a common CJC-1295 without DAC ipamorelin dosage is 100 mcg of each peptide injected two to three times per day. Many protocols keep total daily intake between 200 mcg and 300 mcg of each compound, though exact amounts vary by body weight, goal, and study design. Neither peptide is FDA-approved for human use in the United States.

What CJC-1295 Without DAC and Ipamorelin Are

CJC-1295 without DAC, also called Mod GRF 1-29, is a growth hormone-releasing hormone analog with a short half-life. Ipamorelin is a selective growth hormone secretagogue that tends to produce fewer side effects than older peptides like GHRP-6.

Researchers often combine them because they act on different receptors. The pairing is thought to produce a stronger, more natural pulse of growth hormone than either peptide alone.

Typical CJC-1295 Without DAC and Ipamorelin Dosage

Most published and community research protocols use equal parts of each peptide. The table below summarizes the most frequently cited dosing ranges.

A common research dose is 100 mcg of CJC-1295 without DAC plus 100 mcg of ipamorelin, injected two to three times per day. Doses above 200 mcg per injection of each peptide are less common and may increase side effects like hunger, flushing, or headache.

Dosing by Body Weight

Some researchers prefer weight-based dosing. A range of 1 to 2 mcg per kilogram of body weight for each peptide is often cited. For a 100 kg subject, that equals 100 to 200 mcg of each compound per injection.

Once-Daily vs. Multiple Daily Injections

Because CJC-1295 without DAC has a half-life of roughly 30 minutes, most protocols split the dose into two or three injections. A single larger dose before bed is also used, but it may not mimic natural growth hormone pulses as closely.

Frequency and Timing

When researchers look up cjc 1295 without dac dosage per week, the answer depends on how many injections per day the protocol uses. At two injections per day, a 100 mcg dose equals 1,400 mcg (1.4 mg) per week of each peptide.

• Morning injection: often done on an empty stomach.
• Post-workout injection: used in some bodybuilding protocols.
• Before-bed injection: timed to coincide with natural growth hormone release during sleep.

Injections are typically spaced at least three to four hours apart to avoid receptor desensitization.

The 5mg/5mg and 10mg Blend Dosages

A vial labeled cjc-1295 without dac 5mg ipamorelin 5mg contains equal amounts of each peptide in a single lyophilized powder. Researchers reconstitute the blend with bacteriostatic water, then draw a dose that delivers the target micrograms of each compound.

The cjc-1295 no dac ipamorelin 10mg blend dosage is simply double the 5mg/5mg blend on a per-milligram basis. A 10mg blend (5mg + 5mg) keeps the same ratio; a 20mg blend (10mg + 10mg) would be double that. Always check the label because blend ratios vary by vendor.

For example, if a 5mg/5mg blend is reconstituted with 2.5 mL of water, each 0.1 mL (10 units on an insulin syringe) delivers 200 mcg of each peptide. A 10mg/10mg blend with the same water volume would deliver 400 mcg per 0.1 mL, so half the volume is needed for the same dose.

CJC-1295 With DAC vs Without DAC

The choice between cjc-1295 ipamorelin with dac or without comes down to injection frequency and half-life. CJC-1295 with DAC binds to albumin and stays active for about a week. CJC-1295 without DAC is cleared in about 30 minutes.

CJC-1295 without DAC has a half-life of about 30 minutes, while CJC-1295 with DAC stays active for roughly a week. Because of that long half-life, CJC-1295 with DAC is usually injected only once or twice per week. That lower frequency is convenient, but it can also cause a continuous growth hormone bleed rather than natural pulses.

Bodybuilding and Performance Research

In bodybuilding communities, cjc-1295 without dac dosage bodybuilding discussions often center on 100 to 200 mcg per injection, two to three times daily. The goal is to support lean mass, recovery, and sleep quality. However, no large clinical trials support these performance claims.

Stacking with other peptides is common in informal reports, but it increases unknown risks. Anyone considering these compounds should consult a licensed healthcare professional first.

Safety, Side Effects, and Legal Status

CJC-1295 without DAC and ipamorelin are research chemicals. They are not FDA-approved for human use in the United States. Selling them for human consumption is illegal, though they are widely sold as “for research use only.”

• Common reported side effects: injection-site irritation, flushing, hunger, headache, and fatigue.
• Less common: water retention, joint pain, and numbness or tingling.
• Long-term safety data in humans are limited.

Quality control is a major concern. Third-party testing for purity and sterility is not guaranteed. Always consult a healthcare professional before using any peptide.